263 related articles for article (PubMed ID: 27799636)
1. Implications of Plasmodium vivax Biology for Control, Elimination, and Research.
Olliaro PL; Barnwell JW; Barry A; Mendis K; Mueller I; Reeder JC; Shanks GD; Snounou G; Wongsrichanalai C
Am J Trop Med Hyg; 2016 Dec; 95(6 Suppl):4-14. PubMed ID: 27799636
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium vivax in the Era of the Shrinking P. falciparum Map.
Price RN; Commons RJ; Battle KE; Thriemer K; Mendis K
Trends Parasitol; 2020 Jun; 36(6):560-570. PubMed ID: 32407682
[TBL] [Abstract][Full Text] [Related]
3. Control and elimination of Plasmodium vivax.
Shanks GD
Adv Parasitol; 2012; 80():301-41. PubMed ID: 23199491
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium vivax - How hidden reservoirs hinder global malaria elimination.
Angrisano F; Robinson LJ
Parasitol Int; 2022 Apr; 87():102526. PubMed ID: 34896312
[TBL] [Abstract][Full Text] [Related]
5. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
[TBL] [Abstract][Full Text] [Related]
6. Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes.
Maneerattanasak S; Gosi P; Krudsood S; Chimma P; Tongshoob J; Mahakunkijcharoen Y; Sukasem C; Imwong M; Snounou G; Khusmith S
Malar J; 2017 May; 16(1):228. PubMed ID: 28558712
[TBL] [Abstract][Full Text] [Related]
7. Identification of the asymptomatic Plasmodium falciparum and Plasmodium vivax gametocyte reservoir under different transmission intensities.
Koepfli C; Nguitragool W; de Almeida ACG; Kuehn A; Waltmann A; Kattenberg E; Ome-Kaius M; Rarau P; Obadia T; Kazura J; Monteiro W; Darcy AW; Wini L; Bassat Q; Felger I; Sattabongkot J; Robinson LJ; Lacerda M; Mueller I
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009672. PubMed ID: 34449764
[TBL] [Abstract][Full Text] [Related]
8. Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.
de Jong RM; Tebeje SK; Meerstein-Kessel L; Tadesse FG; Jore MM; Stone W; Bousema T
Immunol Rev; 2020 Jan; 293(1):190-215. PubMed ID: 31840844
[TBL] [Abstract][Full Text] [Related]
9. Development of vaccines for Plasmodium vivax malaria.
Mueller I; Shakri AR; Chitnis CE
Vaccine; 2015 Dec; 33(52):7489-95. PubMed ID: 26428453
[TBL] [Abstract][Full Text] [Related]
10. Global Epidemiology of Plasmodium vivax.
Howes RE; Battle KE; Mendis KN; Smith DL; Cibulskis RE; Baird JK; Hay SI
Am J Trop Med Hyg; 2016 Dec; 95(6 Suppl):15-34. PubMed ID: 27402513
[TBL] [Abstract][Full Text] [Related]
11. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting.
Harris I; Sharrock WW; Bain LM; Gray KA; Bobogare A; Boaz L; Lilley K; Krause D; Vallely A; Johnson ML; Gatton ML; Shanks GD; Cheng Q
Malar J; 2010 Sep; 9():254. PubMed ID: 20822506
[TBL] [Abstract][Full Text] [Related]
12. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite.
Mueller I; Galinski MR; Baird JK; Carlton JM; Kochar DK; Alonso PL; del Portillo HA
Lancet Infect Dis; 2009 Sep; 9(9):555-66. PubMed ID: 19695492
[TBL] [Abstract][Full Text] [Related]
13. Very high carriage of gametocytes in asymptomatic low-density Plasmodium falciparum and P. vivax infections in western Thailand.
Nguitragool W; Mueller I; Kumpitak C; Saeseu T; Bantuchai S; Yorsaeng R; Yimsamran S; Maneeboonyang W; Sa-Angchai P; Chaimungkun W; Rukmanee P; Puangsa-Art S; Thanyavanich N; Koepfli C; Felger I; Sattabongkot J; Singhasivanon P
Parasit Vectors; 2017 Oct; 10(1):512. PubMed ID: 29065910
[TBL] [Abstract][Full Text] [Related]
14. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
Elife; 2014 Nov; 3():. PubMed ID: 25406065
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH
Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544
[TBL] [Abstract][Full Text] [Related]
16. Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination.
Arnott A; Barry AE; Reeder JC
Malar J; 2012 Jan; 11():14. PubMed ID: 22233585
[TBL] [Abstract][Full Text] [Related]
17. [Role of primaquine in malaria control and elimination in French-speaking Africa].
Briolant S; Pradines B; Basco LK
Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
[TBL] [Abstract][Full Text] [Related]
18. The Biology of
Adams JH; Mueller I
Cold Spring Harb Perspect Med; 2017 Sep; 7(9):. PubMed ID: 28490540
[No Abstract] [Full Text] [Related]
19. Blood-stage dynamics and clinical implications of mixed Plasmodium vivax-Plasmodium falciparum infections.
Mason DP; McKenzie FE
Am J Trop Med Hyg; 1999 Sep; 61(3):367-74. PubMed ID: 10497972
[TBL] [Abstract][Full Text] [Related]
20. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
Bassat Q
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1325. PubMed ID: 22216359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
